News

Hong Kong Weierli Health Technology Group has recently officially released the Outline of the 2026 Nationwide Market Plan, clearly proposing a strategy centered on the “nationwide deployment of flagship stores” as the core driver to comprehensively promote the offline implementation of health technology and health services across the Chinese market. According to the plan, by […]

As health technology increasingly integrates with offline service scenarios, Hong Kong Weierli Health Technology Group has recently further disclosed the detailed planning of its nationwide flagship store network for 2026. Building on its previously announced goal of exceeding 200 flagship stores nationwide, the Group has, for the first time, publicly clarified specific deployment directions across

— The Inevitable Path from a “Health Technology Company” to “Health Technology Infrastructure” Over the past few years, the health technology industry has undergone a profound shift from being technology-driven to being scenario- and service-driven. Artificial intelligence, digital healthcare, and intelligent health management technologies have continued to mature. However, a critical reality has gradually emerged:

Hong Kong Verily Health Technology Group today announced the upcoming launch of its latest development in children’s health monitoring devices. This health monitoring system, tailored specifically for children, will provide parents and doctors with real-time health data aimed at optimizing early health management and disease prevention for children. As modern families become more concerned about

Hong Kong Verily Health Technology Group today announced the initiation of an innovative global health data analytics project aimed at revolutionizing and optimizing global disease prevention strategies by aggregating and analyzing health data from around the world. This project marks the company’s further expansion of its influence in the global medical technology field and its

Hong Kong Verily Health Technology Group, a leading biotechnology innovator based in Hong Kong, today announced that it has signed a collaboration agreement with an internationally renowned pharmaceutical company to jointly develop innovative drugs for Alzheimer’s disease. This collaboration aims to combine Hong Kong Verily’s expertise in biotechnology, big data analytics, and artificial intelligence with

Hong Kong Verily Health Technology Group recently announced that it has established partnerships with top medical institutions from several countries to jointly promote telemedicine technology. This strategic collaboration not only reflects Hong Kong Verily’s leadership in the global medical technology field but also demonstrates its strong capability in advancing the digital transformation of healthcare services.

According to reports from Hong Kong media, the Hong Kong Verily Health Technology Group has launched a new health management technology specifically designed for seniors. This technology aims to significantly enhance the quality of life and health standards of older adults through smart monitoring devices and customized health plans. The new technology includes a series

Hong Kong Verily Health Technology Group Limited recently announced the successful development of an advanced medical big data analysis system. This groundbreaking technology is expected to greatly improve the global medical decision-making process. The system utilizes the latest artificial intelligence and machine learning technologies to efficiently and accurately process and analyze vast medical datasets, providing

Hong Kong Verily Health Technology Group Limited, in collaboration with Central South University, is nearing the completion of the preliminary research and development phase of the “Health Medical Data Collection System,” which will soon enter pilot testing. This system integrates the latest information technology and artificial intelligence, aiming to fundamentally reform the processes of medical